PYC Therapeutics
Bridget Flis has work experience as a Research Officer at PYC Therapeutics (ASX: PYC) starting in December 2022, and they have also worked as a Research Assistant at the same company from November 2021 to December 2022. Bridget also has experience as a Research Assistant at The University of Western Australia, starting in December 2021 and ending in January 2022.
Bridget Flis completed their Bachelor of Biomedical Science at The University of Western Australia from 2018 to 2020. Their field of study during this degree was focused on Neuroscience, as well as Biochemistry and Molecular Biology. After completing their bachelor's degree, Bridget Flis continued their education at The University of Western Australia, where they are currently pursuing a Bachelor of Science (Honours) in Neuroscience. No end year is provided for this ongoing degree.
This person is not in any offices
PYC Therapeutics
1 followers
PYC Therapeutics is a development-stage biotechnology company pioneering a new generation of RNA therapeutics that utilize Cell Penetrating Peptides (CPPs), a revolutionary delivery technology designed to overcome the major challenges of current gene-based therapies.